These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7999846)
1. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients. Kim SS; Hirose S; Tamura H; Nagasawa R; Tokushima H; Mitarai T; Isoda K Adv Perit Dial; 1994; 10():282-5. PubMed ID: 7999846 [TBL] [Abstract][Full Text] [Related]
2. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD. Sjöberg B; Anderstam B; Suliman M; Alvestrand A Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386 [TBL] [Abstract][Full Text] [Related]
3. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Borazan A; Aydemir S; Sert M; Yilmaz A Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053 [TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH). Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753 [TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in children on renal replacement therapy. Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics of hyperhomocysteinemia in dialysis patients]. Lovcić V; Kes P; Reiner Z Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568 [TBL] [Abstract][Full Text] [Related]
8. Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients. Taruangsri P; Ong-Ajyooth L; Ong-Ajyooth S; Chaiyasoot W; Leowattana W; Sritippayawan S; Vareesangthip K; Chanchairujira T; Vasuvattakul S; Shayakul C; Vanichakarn S J Med Assoc Thai; 2005 Oct; 88(10):1373-81. PubMed ID: 16519382 [TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis. Pawlak K; Mysliwiec M; Pawlak D Thromb Res; 2012 Jun; 129(6):704-9. PubMed ID: 21906785 [TBL] [Abstract][Full Text] [Related]
10. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids]. Hirose S; Kim S; Matsuda A; Itakura Y; Matsumura O; Tamura H; Nagasawa R; Mitarai T; Isoda K Nihon Jinzo Gakkai Shi; 1998 Jan; 40(1):8-16. PubMed ID: 9513377 [TBL] [Abstract][Full Text] [Related]
11. Folic acid treatment of hyperhomocysteinemia in dialysis patients. Janssen MJ; van Guldener C; de Jong GM; van den Berg M; Stehouwer CD; Donker AJ Miner Electrolyte Metab; 1996; 22(1-3):110-4. PubMed ID: 8676799 [TBL] [Abstract][Full Text] [Related]
12. Relationships between homocysteine and related amino acids in chronic hemodialysis patients. McDonald SP; Whiting MJ; Tallis GA; Barbara JA Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358 [TBL] [Abstract][Full Text] [Related]
13. Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD). Slow S; Vasudevamurthy M; Fraser R; McEntyre C; Lever M; Chambers S; George P Exp Toxicol Pathol; 2007 Apr; 58(5):285-90. PubMed ID: 17175148 [TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients. Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291 [TBL] [Abstract][Full Text] [Related]
16. [Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients]. Wang HT; Peng YM; Liu H Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):266-8. PubMed ID: 14653086 [TBL] [Abstract][Full Text] [Related]
17. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid. Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386 [TBL] [Abstract][Full Text] [Related]
19. [Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia]. Kimura H; Yoshida H Rinsho Byori; 2002 Aug; 50(8):793-801. PubMed ID: 12373816 [TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Chauveau P; Chadefaux B; Coudé M; Aupetit J; Hannedouche T; Kamoun P; Jungers P Kidney Int Suppl; 1993 Jun; 41():S72-7. PubMed ID: 8320950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]